SCWorx (NASDAQ:WORX – Get Free Report) is one of 954 publicly-traded companies in the “Software” industry, but how does it contrast to its rivals? We will compare SCWorx to related companies based on the strength of its institutional ownership, profitability, analyst recommendations, earnings, valuation, dividends and risk.
Profitability
This table compares SCWorx and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SCWorx | -80.55% | -34.75% | -30.85% |
| SCWorx Competitors | -612.30% | 20.88% | -8.99% |
Earnings & Valuation
This table compares SCWorx and its rivals revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| SCWorx | $2.93 million | -$4.44 million | -0.05 |
| SCWorx Competitors | $1.81 billion | $385.92 million | 111.25 |
SCWorx’s rivals have higher revenue and earnings than SCWorx. SCWorx is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Insider and Institutional Ownership
1.9% of SCWorx shares are held by institutional investors. Comparatively, 41.9% of shares of all “Software” companies are held by institutional investors. 0.4% of SCWorx shares are held by company insiders. Comparatively, 19.8% of shares of all “Software” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
This is a summary of recent recommendations for SCWorx and its rivals, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SCWorx | 1 | 0 | 0 | 0 | 1.00 |
| SCWorx Competitors | 5715 | 21424 | 44683 | 1492 | 2.57 |
As a group, “Software” companies have a potential upside of 27.33%. Given SCWorx’s rivals stronger consensus rating and higher probable upside, analysts clearly believe SCWorx has less favorable growth aspects than its rivals.
Risk and Volatility
SCWorx has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500. Comparatively, SCWorx’s rivals have a beta of 1.34, indicating that their average stock price is 34% more volatile than the S&P 500.
Summary
SCWorx rivals beat SCWorx on 12 of the 13 factors compared.
SCWorx Company Profile
SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion, and automation; electronic medical record management; charge description master management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.
Receive News & Ratings for SCWorx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SCWorx and related companies with MarketBeat.com's FREE daily email newsletter.
